Unfortunately, GLP-1 medications do not reduce stress, resolve anxiety or depression or act as a coping mechanism for other life events
While your bodys natural ability to produce collagen and heal tissue slows down with age, these tiny protein chains signal your cells to get back to work
In this context, glucagon-like peptide-1 receptor (GLP-1R) agonists have been increasingly used in the treatment of pediatric obesity, with evidence supporting their efficacy in reducing body weight, BMI, and improving glycemic control, although gastrointestinal side effects, such as nausea, are common
Most GLP-1 medications are overwhelmingly intake-focused
Diabetes Obes Metab 26(5):16241635